Emanuel Petricoin, PhD profile page

Dr. Emanuel F Petricoin has been the Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a University Professor. Prior to this position, he served as Co-Director of the FDA-NCI Clinical Proteomics Program from 2001-2005, and a Senior Investigator within the Center for Biologics Evaluation and Research at the US Food and Drug Administration from 1993-2005. The focus of the CAPMM is the invention and use of proteomics technologies for personalized therapy, molecular diagnostics and biomarker discovery. Dr. Petricoin’s expertise includes precision medicine, proteomics and protein biomarkers, cell signaling, molecular diagnostic assay development, biologics and cellular therapeutics regulation, as well as artificial intelligence-based algorithms.

Dr. Petricoin is a founding member of the Human Proteomic Organization (HUPO), has co-authored over 400 publications, and is a co-inventor on over 40 filed and published patents.